๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Rentech in another GTL licensing move

Publisher
Elsevier Science
Year
2003
Weight
35 KB
Volume
2003
Category
Article
ISSN
1351-4180

No coin nor oath required. For personal study only.

โœฆ Synopsis

are competitive and has joined up with Genencor to develop a bio-based route.

๐Ÿ“œ SIMILAR VOLUMES

Rentech continues its GTL licensing spre
Rentech continues its GTL licensing spree
๐Ÿ“‚ Article ๐Ÿ“… 2003 ๐Ÿ› Elsevier Science โš– 33 KB

development and production of pharmaceutical intermediates. AHF integrates the introduction of versatile aldehyde functionality with the formation of a chiral centre. Dow's new generation of chiral bisphosphite ligands is claimed to expand the scope of the technology beyond the vinylarene substrates

Rentech to license floating GTL technolo
Rentech to license floating GTL technology
๐Ÿ“‚ Article ๐Ÿ“… 2003 ๐Ÿ› Elsevier Science โš– 31 KB

R&D costs rose by 5% to DKR 713 M for 2002. The group generated profit of DKR 644 M after tax for 2002. Headquartered in Denmark, Novozymes A/S is a biotech-based world leader in enzymes and microorganisms for industrial use. Novozymes also applies its core competences in selected pharmaceutical are